Skip to main content
. 2021 Dec 30;14(1):87. doi: 10.3390/pharmaceutics14010087

Table 1.

The design of the spray drying experiments.

Formulation a Spray Solution Composition b
[% w/w in Deionized Water]
Nominal Particle Composition
[% w/w]
Drug Mannitol Leucine Ethanol Drug Mannitol Leucine
M1L0E25 0.113 0.638 0.000 24.813 15.00 85.00 0.00
M2L1E25 0.113 0.425 0.212 24.813 15.00 56.70 28.31
M1L2E25 0.113 0.212 0.425 24.813 15.00 28.31 56.70
M0L1E25 0.113 0.000 0.638 24.813 15.00 0.00 85.00
M1L0E50 0.113 0.638 0.000 49.625 15.00 85.00 0.00
M2L1E50 0.113 0.425 0.212 49.625 15.00 56.70 28.31
M1L2E50 0.113 0.212 0.425 49.625 15.00 28.31 56.70
M0L1E50 0.113 0.000 0.638 49.625 15.00 0.00 85.00

a Formulation codes are expressed in the form MxLyEz, where x:y w/w is the mannitol:leucine ratio and z% w/w is the concentration of ethanol in the spray solvent. b All spray solutions contained hydrochloric acid at a concentration of 0.01 mol/kg. For all formulations, the total solute concentration in the spray solution was 0.75% w/w and the nominal drug:total excipient ratio was 15:85 w/w.